If you’ve been on Saxenda for a while and your progress has slowed, you might be thinking about switching to Wegovy. For many people, the Saxenda to Wegovy transition becomes a natural next step when weight loss plateaus or daily injections become harder to maintain.
But how does that change actually work? What should you expect along the way?
Let’s take a closer look at what both drugs do, why people make the switch, and what studies and real experiences reveal about it.
🔑 Key takeaways
|
What are Saxenda and Wegovy?
Saxenda and Wegovy belong to the same family of medicines called GLP-1 receptor agonists. These medicines copy a natural hormone that helps control appetite, digestion, and blood sugar. Both help you feel full sooner, stay full longer, and reduce cravings for snacks. They also slow how fast your stomach empties, which means you’re less likely to overeat.
Even though they work in similar ways, their main ingredients are different. Here’s why:
- Saxenda contains liraglutide
- Wegovy contains semaglutide
They act on the same receptor, but semaglutide stays active in the body much longer, which is about 165 hours compared with 13 to 15 hours for liraglutide. This is why Wegovy is injected once a week, while Saxenda must be taken every day.
Dosing and schedule differences
Saxenda starts with a daily dose of 0.6 mg in the first week and increases weekly until reaching 3 mg daily. Wegovy, on the other hand, starts with a weekly dose of 0.25 mg and increases step-by-step until it reaches 2.4 mg per week.
| Medication | Dose schedule | Starting dose | Titration frequency | Maximum dose |
| Saxenda | Daily injection | 0.6 mg/day (Week 1) | Increases weekly | 3 mg/day |
| Wegovy | Weekly injection | 0.25 mg/week | Increases step-by-step (weekly) | 2.4 mg/week |
That simple change, from daily to weekly, is one of the biggest reasons people switch. A once-a-week injection feels easier to manage than remembering a daily one. It also gives your body time to adjust between doses.
Approved uses and extra benefits
Both medications are approved for weight loss and long-term weight management in adults and teens aged 12 or older. They can also be used in adults with overweight and at least one weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes.
But Wegovy has a few extra approved uses.
It can lower the risk of major heart problems like heart attack and stroke in adults with obesity and heart disease. It’s also approved to treat certain liver conditions, including metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced fibrosis. These broader benefits make Wegovy a more versatile choice for some people.
Why might people choose a Saxenda to Wegovy transition (liraglutide to semaglutide)?
For some, transitioning from liraglutide to semaglutide feels like a natural GLP-1 upgrade, especially when weight-loss progress plateaus. This shift can offer renewed momentum, improved convenience, or better overall tolerance.
When progress slows
For many, Saxenda works well at first but can plateau over time. Reddit user markosharkNZ shared that they lost weight at the start but stayed around 120 kg for six months, even after increasing exercise. They hoped switching to Wegovy would “kickstart things again.”
Source: NA
Plateaus like that are common. As your body adapts, weight loss can slow down. Moving to Wegovy may help restart progress because of its stronger effect and longer activity in the body.
Fewer side effects for some users
Not everyone responds to medications the same way. Some people report smoother experiences on Wegovy.
One Reddit user, TropicalBlueWater, said they finished Saxenda one day and started Wegovy the next. They noticed no side effects and fewer injection site reactions compared to Saxenda.
Others, however, mentioned mild nausea or stomach upset after their first few doses of Wegovy.
Side effects can vary. Some users find Wegovy easier to tolerate, while others prefer Saxenda.
For instance, Ollie-95 experienced stomach flu-like symptoms 24 hours after their Wegovy injection but said that “food noise” was much quieter, meaning fewer cravings.
Convenience and availability
Daily injections can be tough to maintain. A weekly schedule with Wegovy fits more easily into a busy life. Another big reason for switching is availability. Many people, like Ollie-95, stopped Saxenda because pharmacies ran out of stock. When refills weren’t possible, they moved to Wegovy, which was easier to get.
Supply problems and cost differences often influence the decision to switch. For some, insurance coverage or national approvals also play a role.
As markosharkNZ noted, Mounjaro wasn’t yet approved for weight loss in Australia, so Wegovy became the next best option.
Stronger effectiveness
In clinical trials, Wegovy produced almost double the average weight loss seen with Saxenda. Participants using Wegovy lost about 15.8% of their starting body weight, compared to 6.4% with Saxenda.
The same pattern appeared across several studies, confirming that Wegovy often leads to greater results when paired with diet and exercise.
How to transition from Saxenda to Wegovy safely
Switching GLP-1 medications can feel confusing, but a Saxenda to Wegovy transition is usually straightforward with the right guidance.
Here’s a simple, safe way to move from one treatment to the other.
Step 1: Consult your healthcare provider
Switching between GLP-1 medications isn’t something to do on your own. Your doctor will check the following before recommending a plan:
- Your progress
- Your health conditions
- Your past side effects
They might also adjust your other medications, especially if you take something for diabetes, since GLP-1 drugs can affect blood sugar levels.
Step 2: Transition carefully
| Dosing Information | What to do |
| Starting Wegovy dose | Begin at 0.25 mg per week, even if you were on the full 3.0 mg Saxenda dose. |
| Dose escalation | Increase the Wegovy dose every four weeks until you reach your maintenance level. |
As discussed in many Saxenda vs Wegovy dosing switch guide recommendations, some people may be instructed by their doctors to stop Saxenda one day and start Wegovy within the next 24 to 48 hours. Others might be advised to wait a few days to allow Saxenda to clear from the body.
In most cases, you’ll begin Wegovy at the starting dose of 0.25 mg per week, even if you were previously on the full 3.0 mg Saxenda dose.
Starting low helps reduce nausea and stomach discomfort. Your provider will gradually raise your dose every four weeks until you reach your maintenance level.
Step 3: Expect some temporary changes
It’s normal to feel a little hungrier in the first few weeks because you’re moving from a higher daily dose to a lower weekly one. This effect usually fades as your Wegovy dose increases. If you notice symptoms like nausea, fatigue, or appetite spikes, let your healthcare team know because they can help you manage them.
Step 4: Continue lifestyle support
The best results happen when Wegovy is combined with healthy eating and regular activity. In fact, every major study paired the treatment with diet and exercise programs.
Staying consistent helps your body respond better and keeps the weight off long-term.
Clinical studies about efficacy, adherence, and switching among GLP-1 therapies
Clinical research shows that Wegovy leads to significantly greater weight loss and higher long-term adherence compared with Saxenda, which are key reasons many patients consider a Saxenda to Wegovy transition.
Clinical trial findings
Several studies have compared Saxenda and Wegovy side by side.
In the STEP 8 randomized clinical trial, adults taking Wegovy lost an average of 15.8% of their weight after 68 weeks, while those on Saxenda lost about 6.4%. These results align with earlier findings from another study, confirming Wegovy’s stronger effect.
Researchers also noted fewer dropouts with Wegovy. Only 3.2% of participants stopped treatment because of side effects, compared to 12.6% of Saxenda users.
That means most people found Wegovy easier to tolerate over time.
Real-world experience
Outside clinical trials, people’s experiences can be mixed.
On Reddit, users shared stories of both success and frustration. BrilliantNet9302 lost 35 pounds in three months on Wegovy after a full year on Saxenda without results. Spoilerzz, on the other hand, said they had better consistency and fewer side effects on Wegovy than with Ozempic or Saxenda, though they struggled with prescription shortages.
A real-world analysis published in the Journal of Managed Care & Specialty Pharmacy found that among people using GLP-1 drugs for weight loss, persistence after one year was only 32.3% overall.
However, semaglutide users (Wegovy/Ozempic) had the highest persistence at 47.1%, while liraglutide (Saxenda) users had the lowest at 19.2%. That shows people tend to stay on Wegovy longer and follow their treatment more consistently.
| 🤔 Why switching matters According to a study, switching between GLP-1 therapies is common. People often change medications because of side effects, cost, or limited results. The good news is that switching can be safe and effective when managed properly. Doctors usually recommend it to improve tolerability, simplify dosing, or enhance weight loss results. |
Final words
Both Saxenda and Wegovy belong to the same family and work in similar ways, but Wegovy often leads to more significant and sustained weight loss, which makes the Saxenda to Wegovy transition a common consideration for many patients.
Still, no two bodies respond the same. Some people thrive on Saxenda, others on Wegovy, and some need a different option entirely. What matters most is having a healthcare provider guide you through the process, adjusting your plan as needed.
So, if you’ve hit a plateau or find daily injections hard to manage, talk to your doctor about Wegovy.
FAQs about Saxenda to Wegovy transition
Does switching to Wegovy reduce injections?
No. Switching to Wegovy does not reduce injection frequency; it still requires a once-weekly subcutaneous injection.
How soon can I start Wegovy after stopping Saxenda?
You can usually start Wegovy the day after your last Saxenda shot. Some providers suggest waiting 48 hours to lower side-effect risks. Follow your doctor’s plan.
Do I need a wash-out period when switching?
No. Most guidance says no wash-out is needed. Wegovy can start right after stopping Saxenda.
What dose of Wegovy do I start with?
You’ll begin at 0.25 mg weekly, even if you were on a high Saxenda dose. This helps your body adjust and reduces stomach side effects.
How does the Wegovy dose increase?
You usually increase every 4 weeks: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg (target dose). Your doctor may slow down if you have side effects.
Why switch from Saxenda to Wegovy?
Wegovy often leads to more weight loss than Saxenda in studies. It’s also once weekly, not daily, which many people prefer.
Will Wegovy work if Saxenda didn’t help me?
Yes, it might. Many people who saw little progress on Saxenda lose more weight on Wegovy because it is stronger and more effective.
Is it safe to stop Saxenda suddenly?
Don’t stop on your own. Saxenda usually can be stopped without tapering, but you should talk to your doctor first to avoid issues.
How long does Saxenda stay in my body?
Saxenda stays in your system for about 3 days. This is why some providers suggest waiting 48 hours before taking Wegovy.
What side effects should I expect when switching?
You may feel nausea, vomiting, or stomach upset, especially when starting Wegovy. Beginning at the lowest dose and increasing slowly helps.
Can I switch from Saxenda to Ozempic the same way?
Yes. Like Wegovy, Ozempic is semaglutide. Many providers start Ozempic the day after your last Saxenda dose, usually at 0.25 or 0.5 mg weekly.
Sources
- U.S. Food and Drug Administration. (2024). Wegovy (semaglutide) injection: Highlights of prescribing information. U.S. Department of Health and Human Services. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215256s011lbl.pdf
- Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. The New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
- Rubino, D. M., Greenway, F. L., Khalid, U., et al. (2022). Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: The STEP 8 randomized clinical trial. JAMA, 327(2), 138–150. https://doi.org/10.1001/jama.2021.23619
- Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C. W., le Roux, C. W., Ortiz, R. V., Jensen, C. B., & Wilding, J. P. H., for the SCALE Obesity and Prediabetes NN8022-1839 Study Group. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. The New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892
- Gleason, P. P., Urick, B. Y., Marshall, L. Z., Friedlander, N., Qiu, Y., & Leslie, R. S. (2024). Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes. Journal of Managed Care & Specialty Pharmacy, 30(8). https://doi.org/10.18553/jmcp.2024.23332
Author Bio: Dr. Adrian Blackwell is the founder and CEO of PonteVita Rx, a telehealth practice dedicated to making medication access simpler, more affordable, and less stressful. Licensed to practice medicine in all 50 states and DC, Dr. Blackwell is board certified in obesity medicine and emergency medicine. He combines clinical expertise with personal experience navigating the healthcare system as a patient and parent to children with chronic illnesses. His mission: ensure everyone has access to their necessary medications without unnecessary barriers.
Medical Disclaimer: All the information here, on these videos, YouTube, social media, or in any other format, is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always consult your personal physician or other qualified health provider with any questions you may have regarding a medical condition. Never replace professional medical advice given to you personally or delay in seeking it because of something you have read or heard on this website. This information is not meant to diagnose, treat, or cure any medical condition. No patient-physician relationship is formed. If you’re my patient, please text me before you make any changes to your medication. If you believe you are having a medical emergency please call 911.